|
|
 |
Adenovir Pharma Links:
Adenovir Pharma AB is a project company within P.U.L.S. AB
 P.U.L.S AB
Partners for Development investments in Life Sciences, P.U.L.S. AB (”PULS”) was founded in 2002. PULS acts as a investor and incubator for early projects within life science, mostly drug development and has so far started seven project companies.
PULS consist of an operational management team and twenty partners with long experience in life sciences and competence through the whole value chain, from R&D to commercialization.
The business model for PULS is to engage early with innovators to attain an optimal IP platform and high quality development throughout the project. By providing capital, knowledge and cost effective management, the common objective is to maximize, clarify and realize the value of project ideas through a successful exit.
|
|
|
|
